Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
DOI: 10.1126/science.119.3097.623 3
Learn more World-class advisors Backed by the Leading Experts in Metabolic Health David Perlmutter MD, F.A.C.N Five-time New York Times bestselling author of Drop Acid Professor and lecturer Ben Bikman PhD Author of Why We Get Sick Scientist, researcher, professor Board member - American Diabetes Society Rob Lustig MD, MSL Professor Emeritus of Pediatrics, Division of Endocrinology Sara Gottfried MD Author of many books, including Women, Food, and Hormones Physician-scientist, global keynote speaker, clinical assistant professor Dom D'Agostino PhD Research scientist and professor Terry Wahls MD Author of The Wahls Protocol Clinical professor and researcher LEVELS APP MEMBERSHIP Food Logging & Macro Tracking AI-POWERED Log and track your meals with AI Take control of your health journey with intelligent tools that simplify meal logging

Wipanee, representing BSL, provided an update on knowledge trends with in-depth insights into skin care from CICM 2025, bringing them back to further develop treatment methods for our clients